Ying Jin

987 total citations
37 papers, 706 citations indexed

About

Ying Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ying Jin has authored 37 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Ying Jin's work include Cancer-related Molecular Pathways (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Pelvic floor disorders treatments (2 papers). Ying Jin is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Pelvic floor disorders treatments (2 papers). Ying Jin collaborates with scholars based in China, United States and United Kingdom. Ying Jin's co-authors include Zhimin Fan, Chang Liu, Carmen Page, Melinda Huang, Valerie P. Castle, Huey Lin, Jiayuh Lin, Qing Miao, Ji‐Liang Li and Suwen Feng and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Developmental Biology.

In The Last Decade

Ying Jin

37 papers receiving 690 citations

Peers

Ying Jin

ONCOL

IMMUN

PFM

Ruixia Huang Norway

Tiago De Oliveira Germany

Aurélie Courtin France

Jon Smythe United Kingdom

Angela Kueck United States

Sharareh Siamakpour‐Reihani United States

Alexander Jorge Cortez Poland

Dongkyoo Park United States

Wenxiao Jiang China

Ruixia Huang Norway

Ying Jin

374 ×1.0

247 ×1.3

ONCOL

215 ×1.4

79 ×1.0

IMMUN

49 ×0.8

PFM

Citations per year, relative to Ying Jin Ying Jin (= 1×) peers Ruixia Huang

Countries citing papers authored by Ying Jin

Since Specialization

Citations

This map shows the geographic impact of Ying Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jin more than expected).

Fields of papers citing papers by Ying Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jin. The network helps show where Ying Jin may publish in the future.

Co-authorship network of co-authors of Ying Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Jin. A scholar is included among the top collaborators of Ying Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Jin. Ying Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Ying, et al.. (2023). A new approach to overcoming resistance to immunotherapy: nanotechnology. Frontiers in Oncology. 13. 1210245–1210245. 5 indexed citations

Jin, Ying, et al.. (2023). Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems. Cancer Medicine. 12(10). 11049–11072. 16 indexed citations

Xu, Ping, Ying Jin, Pingping Guo, et al.. (2023). Barriers and enablers of pelvic floor rehabilitation behaviours in pregnant women with stress urinary incontinence: a qualitative analysis using the theoretical domains framework. BMC Pregnancy and Childbirth. 23(1). 300–300. 9 indexed citations

Zhang, Kai, Yang Cao, Junjun Liu, et al.. (2022). Activatable “Matryoshka” nanosystem delivery NgBR siRNA and control drug release for stepwise therapy and evaluate drug resistance cancer. Materials Today Bio. 14. 100245–100245. 6 indexed citations

Liu, Chang, Sijie Li, Xiaoxiao Zhang, et al.. (2022). Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway. Cancer Gene Therapy. 30(5). 647–658. 12 indexed citations

Liu, Chang, Ying Jin, & Zhimin Fan. (2021). The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer. Frontiers in Oncology. 11. 698023–698023. 136 indexed citations

Chen, Hong, Xiang Liu, Yipeng Lv, et al.. (2021). Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: A systematic review and meta-analysis. PLoS ONE. 16(12). e0261692–e0261692. 14 indexed citations

Zhao, Zhenxing, Yifei Li, Mengjiao Wang, et al.. (2020). Mitochondrial DNA haplogroups participate in osteoarthritis: current evidence based on a meta-analysis. Clinical Rheumatology. 39(4). 1027–1037. 21 indexed citations

He, Yu, et al.. (2020). Quantification of pancreatic elasticity in type 2 diabetes: A new potential imaging marker for evaluation of microangiopathy. European Journal of Radiology. 124. 108827–108827. 3 indexed citations

10.

Jin, Ying & Ji‐Liang Li. (2019). Olfactomedin-like 3. Chinese Medical Journal. 132(14). 1733–1738. 14 indexed citations

11.

Yan, Yi, Zhaojin Yu, Mingli Sun, et al.. (2019). The Analysis of Key Factors Related to ADCs Structural Design. Frontiers in Pharmacology. 10. 373–373. 51 indexed citations

12.

Jin, Ying, Wenquan Hu, Tong Liu, et al.. (2018). Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. Cancer Letters. 419. 233–244. 15 indexed citations

13.

Gao, Pin, Xiang Wang, Ying Jin, et al.. (2018). Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells. Breast Cancer Research. 20(1). 112–112. 11 indexed citations

14.

Jin, Ying, et al.. (2017). Alteration of serum endocan in normal pregnancy and preeclampsia. Clinical and Experimental Obstetrics & Gynecology. 44(3). 419–422. 5 indexed citations

15.

He, Yu, et al.. (2017). Human hepatocyte growth factor inhibits early neointima formation in rabbit abdominal aortae following ultrasound-guided balloon injury. Molecular Medicine Reports. 16(4). 5203–5210. 1 indexed citations

16.

Chen, Ming, Ying Jin, Yalan Bi, et al.. (2015). Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer. Journal of Cancer. 6(5). 412–419. 23 indexed citations

17.

Jin, Ying. (2014). Association of Single Nucleotide Polymorphisms in Tumor Necrosis Factor-Alpha with Cervical Cancer Susceptibility. Cell Biochemistry and Biophysics. 71(1). 77–84. 15 indexed citations

18.

Jin, Ying, et al.. (2014). Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) in ovarian cancer risk. Tumor Biology. 35(6). 5267–5272. 3 indexed citations

19.

Sun, Ming, Changjin Zhu, Bo Tan, Ying Jin, & Yufen Zhao. (2003). Molecular modeling of diastereoisomeric aggregates of L/D ser/histamine amide with 5′-TpTpdC-3′. Journal of Molecular Modeling. 9(2). 84–87. 3 indexed citations

20.

Sofroniew, Michael V., Richard Pannell, Helen Impey, et al.. (2000). The T Cell Oncogene Tal2 Is Necessary for Normal Development of the Mouse Brain. Developmental Biology. 227(2). 533–544. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact